This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Healthcare portfolio manager upbeat for 2014 as Obamacare kicks in

By Covestor

obamacare-healthcare-investing

The glitch-plagued signup period for the Affordable Care Act hasn't slowed the strong rally in healthcare stocks this year, and the sector is on track for a gain of more than 40% for 2013.

The industry's strong performance has powered a 49.3% year-to-date return for the Healthcare Portfolio on Covestor as of Dec. 27 net of fees, compared with a gain of 31.9% for the S&P 500 and 41.2% for the S&P 500 Healthcare Index.

Within the healthcare sector, biotech stocks have been on fire this year. Two ETFs, Market Vectors Biotech (BBH) and iShares Nasdaq Biotechnology (IBB), are up more than 60%.

Chart source: StockCharts.com

"Going into 2014, we still have the challenges of a very rocky Affordable Care Act rollout that should actually benefit healthcare companies as millions of previously uninsured patients in the U.S. will now have greater access to the healthcare system," said Robert Freedland, who manages the Healthcare Portfolio on the Covestor platform.

"Time will tell whether this will be a success or a dismal policy decision," he added. "My own perspective is that putting access to healthcare into the hands of previously unserviced millions is a good thing and that the problems we are currently experiencing will be ironed out over time. In short, I remain optimistic about this area and about investments in this sector."

In Healthcare Portfolio, Freedland hunts for companies with attractive valuations, growth prospects and potential dividends. The holdings range from drug, device, retail sales, electronic medical record, prescription services, and HMO/hospital companies. The portfolio's top five holdings are Illumina (ILMN), Forest Laboratories (FRX), Jazz Pharmaceuticals (JAZZ), St. Jude Medical (STJ) and Medtronic (MDT).

Healthcare stocks, traditionally viewed as a defensive sector less sensitive to the overall economy, have enjoyed multiple tailwinds this year.

"Healthcare stocks took off in 2013, largely due to anticipation of the Affordable Care Act (a.k.a. Obamacare) opening up new 'customers' to many health-care providers," writes Jeff Reeves for MarketWatch. "But I remain convinced the growth in this sector is not just about Obamacare. This is about demographics in the West fueling demand, about emerging markets getting access to advanced medicine and about the stable nature of this industry in any economic environment."

For Americans who signed up for Obamacare on exchanges during the troubled enrollment period, coverage kicks in on Jan. 1.

The big question for investors in 2014 is whether healthcare stocks have gotten too expensive during the run-up to Obamacare going live.

One headwind for the sector is the uncertain impact from sequestration in the U.S., says Morningstar analyst Robert Goldsborough.

"Even Medicare — once viewed as a sacred cow that would never be subject to cuts — is now at risk of undergoing structural changes," he said. "At the same time, the pharmaceutical industry appears set for a rebound, which could help drive the healthcare sector … What’s more, pharmaceutical firms should benefit from improving pipelines, increasing contributions from fast-growing overseas markets, and cost-cutting."

Photo Credit: jfcherry

DISCLAIMER: The investments discussed are held in client accounts as of November 30, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable. Past performance is no guarantee of future results.

Robert Freedland

Robert Freedland

Robert has over 40 years of investment experience and is a full-time optical surgeon. He uses his expertise in the

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs